Monday, October 31, 2016 1:13:18 PM
Business Description ***
MJ Holdings owns and operates a diversified portfolio of assets and properties. Including digital properties, FindaMarijaunadoctor.com and the Toker mobile app, in addition to a revenue producing real estate portfolio.
Verified Company Profile 8/04/2016
Contact Info
4141 N.E. 2nd Avenue
Suite 204-A
Miami, FL 33137
Website: http://www.mjholdingsinc.com
Phone: (305) 455-1800
Email: pr@mjholdingsinc.com
Find us on: Twitter Facebook
ttp://www.otcmarkets.com/stock/MJNE/quote
They have 3 Locations Under There Assets ~>
**** Email From Company ****
Lightshade Dispensaries in colorado is our tenant in 2 locations.
http://lightshade.com/where-to-find-us/
https://www.mainstreet.com/article/21-marijuana-dispensaries-approved-in-aurora-colorado-raring-to-go
Our 3rd location is occupied by a tenant who operates a marijuana grow facility at 5353 Joliet, you can find them on the list of state licensed entities, lic# 402-00996
https://www.colorado.gov/pacific/sites/default/files/Centers%2007012015.pdf
http://www.bizjournals.com/denver/news/2014/07/28/floridas-mj-holdings-ready-to-roll-with-local.html
~~> 2nd email From Company regargding share structure/notes/dilution etc. ******
The issuer is current in its filings.
There is the same amount of shares outstanding as indicated in the last 10-Q, and in previous filings.
Insiders own in excess of 83% of all the outstanding shares.
There are no convertible notes outstanding and nothing that would dilute shareholders, other than approximately 166,666 out of the money warrants that were issued to Medbox in 2014.
On Fri, Oct 28, 2016 at 5:37 PM,
D1sclaimer: I am not a financial advisor or a stock promoter. I am an investor, Period! Do your own DD and make your own investment decisions.
Recent MJNE News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2023 06:45:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 07:09:33 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/19/2023 11:30:18 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM